Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recombinant Zoster Vaccine Significantly Reduces the Impact on Quality of Life Caused by Herpes Zoster in Adult Autologous Hematopoietic Stem Cell Transplant Recipients: A Randomized Placebo-Controlled Trial (ZOE-HSCT).
Curran D, Matthews S, Rowley SD, Young JH, Bastidas A, Anagnostopoulos A, Barista I, Chandrasekar PH, Dickinson M, El Idrissi M, Heras I, Milliken ST, Monserrat Coll J, Navarro Matilla MB, Oostvogels L, Piątkowska-Jakubas B, Quiel D, Sabry W, Schwartz S, Selleslag DLD, Sullivan KM, Theunissen K, Yegin ZA, Yeh SP, Zaja F, Szer J; ZOE-HSCT Study group collaborators. Curran D, et al. Among authors: milliken st. Biol Blood Marrow Transplant. 2019 Dec;25(12):2474-2481. doi: 10.1016/j.bbmt.2019.07.036. Epub 2019 Aug 5. Biol Blood Marrow Transplant. 2019. PMID: 31394276 Free article. Clinical Trial.
Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis.
Dagnew AF, Ilhan O, Lee WS, Woszczyk D, Kwak JY, Bowcock S, Sohn SK, Rodriguez Macías G, Chiou TJ, Quiel D, Aoun M, Navarro Matilla MB, de la Serna J, Milliken S, Murphy J, McNeil SA, Salaun B, Di Paolo E, Campora L, López-Fauqued M, El Idrissi M, Schuind A, Heineman TC, Van den Steen P, Oostvogels L; Zoster-039 study group. Dagnew AF, et al. Lancet Infect Dis. 2019 Sep;19(9):988-1000. doi: 10.1016/S1473-3099(19)30163-X. Epub 2019 Aug 6. Lancet Infect Dis. 2019. PMID: 31399377 Clinical Trial.
Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era: A Retrospective Analysis from the Australasian Bone Marrow Transplant Recipient Registry.
Lwin Y, Kennedy G, Gottlieb D, Kwan J, Ritchie D, Szer J, Milliken S, Browett P, Spencer A, Butler A, Bardy P, Greenwood M, Perera T, He S, McEwan A, Larsen S, Lai H, Purtill D, Tran S, Aarons D, Hamad N. Lwin Y, et al. Biol Blood Marrow Transplant. 2020 Dec;26(12):2252-2261. doi: 10.1016/j.bbmt.2020.08.024. Epub 2020 Aug 27. Biol Blood Marrow Transplant. 2020. PMID: 32861814 Free article.
Unrelated Donor Transplant Recipients Given Thymoglobuline Have Superior GRFS When Compared to Matched Related Donor Recipients Undergoing Transplantation without ATG.
Othman J, Greenwood M, Moore J, Larsen S, Watson AM, Arthur C, Bhattacharyya A, Bilmon I, Blyth E, Bryant A, Bryant C, Dunlop L, Fay K, Gibson J, Hamad N, Kerridge I, Kwan J, Ma D, Micklethwaite K, Milliken S, Panicker S, Stevenson W, Withers B, Wilcox L, Tran S, Gottlieb DJ. Othman J, et al. Biol Blood Marrow Transplant. 2020 Oct;26(10):1868-1875. doi: 10.1016/j.bbmt.2020.06.030. Epub 2020 Jul 5. Biol Blood Marrow Transplant. 2020. PMID: 32640314 Free article.
A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis.
Snowden JA, Biggs JC, Milliken ST, Fuller A, Staniforth D, Passuello F, Renwick J, Brooks PM. Snowden JA, et al. Among authors: milliken st. Bone Marrow Transplant. 1998 Dec;22(11):1035-41. doi: 10.1038/sj.bmt.1701486. Bone Marrow Transplant. 1998. PMID: 9877264 Clinical Trial.
A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis.
Moore J, Brooks P, Milliken S, Biggs J, Ma D, Handel M, Cannell P, Will R, Rule S, Joske D, Langlands B, Taylor K, O'Callaghan J, Szer J, Wicks I, McColl G, Passeullo F, Snowden J. Moore J, et al. Arthritis Rheum. 2002 Sep;46(9):2301-9. doi: 10.1002/art.10495. Arthritis Rheum. 2002. PMID: 12355477 Free article. Clinical Trial.
113 results